STAT+: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger

Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug development, laid off employees after closing a merger last week.

Continue to STAT+ to read the full story…

Tirzepatide May Help Treat Sleep Apnea in People With Obesity

ORLANDO — Tirzepatide (Zepbound) improved symptoms of moderate-to-severe obstructive sleep apnea (OSA) in people with obesity, regardless of positive airway pressure (PAP) use, the phase

June 22, 2024

Orthofix fires CEO, CFO after investigation finds misconduct

Dive Brief: Spine device maker Orthofix Medical on Tuesday said it terminated the employment of its CEO, CFO and chief legal officer after an independent

September 13, 2023

Recreational drug use may worsen outcomes for cardiac intensive care patients

Recreational drug use may be a factor in a significant proportion of admissions to cardiac intensive care, with various substances detected in 1 in 10

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.